$MDCX

$2.48 +$0.03 (1.22%) Close

$MDCX Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 1.9M shares outstanding

Who owns MDCX?

By type of holder

Institutions 100.0% Insiders 0.0% Everyone else 0.0%

Concentration Top 10 holders own 429.0%

Bokhari, Raza 262.7% · Interchange Capital Partners, LLC 85.8%

Institutional ownership

100.0%

0 pts vs last qtr

Institutional holders

+1 vs last qtr

Net shares bought

+270.9K

by institutions in Q2 2026

New / sold out

8 / 7

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

Jane Street Group, LLC NEW +333.7K
XTX Topco Ltd NEW +243.4K

Biggest sellers in Q2 2026

Private Advisor Group, LLC SOLD OUT −240.1K
Interchange Capital Partners, LLC −75.0K

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for Medicus Pharma Ltd in the last 12 months.

Is your stake being diluted?

Diluted share count, FY2023–FY2025

+396.7%

+122.88% a year

Each share's claim on the business

−79.9%

shrank without buying or selling a share

Spent on buybacks vs paid in stock

— vs $2.32M

over 3 fiscal years

Diluted shares, split-adjusted

Buybacks Stock-based comp

How patient are the owners?

Institutional shares by how long they've been held

5+ years0% 3–5 years0% 1–3 years64% Under 1 year36%

Quarterly turnover

28.4%

of institutional shares changed hands

Top 10 managers, median time held

1 quarter

Super Investors

Investment managers reporting MDCX on Form 13F

Holder	Shares	% of company	Change vs last qtr	Held since	% of their book
IC Interchange Capital Partners, LLC	1.6M	85.78%	−75.0K (−4.5%)	2024	0.1%
Shares held by quarter Peak holding1.7M (Q1'25) Change over 8 quarters+1.6M Share of the company85.780% Interchange Capital Partners, LLC's full portfolio →
JS Jane Street Group, LLC	333.7K	18.04%	NEW	Q2 '26	0.0%
Shares held by quarter Peak holding333.7K (Q2'26) Change over 8 quarters+333.7K Share of the company18.040% Jane Street Group, LLC's full portfolio →

Interchange Capital Partners, LLC

1.6M

% of company

85.78%

Change vs last qtr

−75.0K (−4.5%)

Held since

2024

Jane Street Group, LLC

333.7K

% of company

18.04%

Change vs last qtr

NEW

Held since

Q2 '26

25 more super investors behind a free account

See every manager holding Medicus Pharma Ltd, how their position has changed, and how long they've held it.

Institutional Funds

Mutual funds and ETFs reporting MDCX on Form N-PORT; together they hold 1.9% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
IM iShares Micro-Cap ETF iShares Trust	$16K	34.8K	1.88%	0.00%	March 31, 2026
FN Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust	$1.42K	3.7K	0.20%	0.00%	May 31, 2026

iShares Micro-Cap ETF

iShares Trust

Position value

$16K

% of company

1.88%

% of the fund

0.00%

As of

March 31, 2026

Fidelity Nasdaq Composite Index Fund

Fidelity Concord Street Trust

Position value

$1.42K

% of company

0.20%

% of the fund

0.00%

As of

May 31, 2026

2 more funds behind a free account

See every fund holding Medicus Pharma Ltd and how much of the fund the position is.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
BR Bokhari, Raza 5%+ holder 13D · 5.3%	4.9M	262.67%	—	—	—	—
This holder reports through Schedule 13D/G, not a quarterly 13F. Share of the company262.670% Disclosed stake13D · 5.3% View the 13D/G filing →
MK Melani Kenneth R. Insider	409.4K	22.13%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company22.130% Melani Kenneth R.'s insider activity →

Bokhari, Raza

5%+ holder13D · 5.3%

4.9M

% of company

262.67%

Change vs last qtr

—

Held since

—

Melani Kenneth R.

Insider

409.4K

% of company

22.13%

Change vs last qtr

—

Held since

—

1 more holders behind a free account

See every insider and 5%+ holder of Medicus Pharma Ltd.

Comments